HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiaze Yu Selected Research

Jiaze Yu Research Topics

Disease

6Neoplasms (Cancer)
02/2024 - 01/2019
5Hepatocellular Carcinoma (Hepatoma)
01/2024 - 01/2019
3Neoplasm Metastasis (Metastasis)
02/2024 - 08/2022
3Hepatic Encephalopathy
05/2023 - 01/2019
3Hemorrhage
05/2023 - 02/2019
1Ovarian Neoplasms (Ovarian Cancer)
02/2024
1Malignant Mesothelioma
02/2024
1Breast Neoplasms (Breast Cancer)
02/2024
1Colorectal Neoplasms (Colorectal Cancer)
02/2024
1Hypoxia (Hypoxemia)
01/2024
1Liver Neoplasms (Liver Cancer)
01/2024
1Necrosis
11/2023
1Fibrosis (Cirrhosis)
05/2023
1Thrombosis (Thrombus)
01/2023
1Varicose Veins (Varicose Vein)
02/2019
1End Stage Liver Disease
02/2019
1Portal Hypertension
01/2019
1Ascites
01/2018
1Esophageal and Gastric Varices (Esophageal Varices)
01/2018
1Rupture
01/2018

Drug/Important Bio-Agent (IBA)

1Chimeric Antigen ReceptorsIBA
02/2024
1MesothelinIBA
02/2024
1Tirapazamine (SR 4233)IBA
01/2024
1NanovaccinesIBA
01/2024
1ProdrugsIBA
01/2024
1resiquimodIBA
01/2024
1Excipients (Suspending Agents)IBA
01/2024
1Epirubicin (Ellence)FDA LinkGeneric
11/2023
1AnticoagulantsIBA
01/2023
1Ethiodized Oil (Ethiodol)FDA Link
08/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Long Noncoding RNAIBA
01/2022
1Competitive Endogenous RNAIBA
01/2019
1Circular RNAIBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Polidocanol (Laureth)FDA Link
01/2018
1DiureticsIBA
01/2018

Therapy/Procedure

5Therapeutics
01/2024 - 01/2018
4Surgical Portasystemic Shunt (Portosystemic Shunt)
05/2023 - 01/2019
4Transjugular Intrahepatic Portasystemic Shunt
05/2023 - 01/2019
2Microspheres (Microsphere)
11/2023 - 08/2022
1Stents
05/2023
1Immunotherapy
01/2023
1Ligation
01/2018
1Sclerotherapy
01/2018